Patent · US Active

Bispecific binding proteins that bind CD40 and mesothelin

US10233258B2 · kind B2 · utility

12Cited by
4References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2018
Grant dateMar 19, 2019
Priority date—
Expiry dateFeb 23, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.